Treatment of Mild to Moderate Distal Subungual Onychomycosis of the Toenail
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine whether NB002, 0.25%, and 0.5% are safe and
effective in the treatment of distal subungual onychomycosis of the toenail.